Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells

Biochemical Pharmacology

Volumn 51, Issue 8, 1996, Pages 1069-1076

  Chen, Ichen ^a   Safe, Stephen ^a   Bjeldanes, Leonard ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ah receptor antagonist; diindolylmethane; indole 3 carbinol; T47D cells

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 INDOLEMETHANOL; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 ISOENZYME; ETHOXYRESORUFIN DEETHYLASE; MESSENGER RNA; PARTIAL AGONIST; RADIOLIGAND;

ARTICLE; BINDING AFFINITY; BRASSICA; BREAST CANCER; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROSOME; PRIORITY JOURNAL; REPORTER GENE; VEGETABLE;

EID: 0029959032     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00060-3     Document Type: Article

References (54)

1. Wattenburg LW and Loub WD, Inhibition of aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res 38: 1410-1413, 1978.
2. Stoewsand GS, Anderson JL and Munson L, Protective effect of dietary brussels sprouts against mammary carcinogenesis in Sprague-Dawley rats. Cancer Lett 39: 199-207, 1988.
3. Wattenberg LW, Inhibition of chemical carcinogenesis. J Natl Cancer Inst 60: 11-18, 1978.
4. Bradlow HL, Michnovicz JJ, Telang NT and Osborne MP, Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12: 1571-1574, 1991.
5. Morse MA, LaGreca SD, Amin SG and Chung FL, Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res 50: 2613-2617, 1990.
6. 1 carcinogenesis in rainbow trout by flavone and indole compounds. Carcinogenesis 5: 615-619, 1984.
7. Kojima T, Tanaka T and Mori H, Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 54: 1446-1449, 1994.
8. Tanaka T, Mori Y, Morishita Y, Hara A, Ohno T, Kojima T and Mori H, Inhibitory effect of sinigrin and indole-3-carbinol in diethylnitrosamine-induced hepatocarcinogenesis in male ACI/N rats. Carcinogenesis 11: 1403-1406, 1990.
9. Tanaka T, Kojima T, Morishita Y and Mori H, Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Jpn J Cancer Res 83: 835-842, 1992.
10. Loub WD, Wattenberg LW and Davis DW, Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants. J Natl Cancer Inst 54: 985-988, 1975.
11. Vang O, Jensen MB and Autrup H, Induction of cytochrome P4501A1 in rat colon and liver by indole-3-carbinol and 5,6-benzoflavone. Carcinogenesis 11: 1259-1263, 1990.
12. Michnovicz JJ and Bradlow HL, Induction of estradiol metabolism by dietary indole-3-carbinol in humans. J Natl Cancer Inst 82: 947-949, 1990.
13. Bradfield CA and Bjeldanes LF, Effect of dietary indole-3-carbinol on intestinal and hepatic monooxygenase, glutathione S-transferase and epoxide hydrolase activities in the rat. Food Chem Toxicol 22: 977-992, 1984.
14. Bradfield CA and Bjeldanes, LF, Structure-activity relationships of dietary indoles: A proposed mechanism of action as modifiers of xenobiotic metabolism. J Toxicol Environ Health 21: 311-323, 1987.
15. Jellinck PH, Forkert PG, Riddick DS, Okey AB, Michnovicz JJ and Bradlow HL, Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 45: 1129-1136, 1993.
16. Baldwin WS and LeBlanc GA, The anti-carcinogenic plant compound indole-3-carbinol differentially modulates P450-mediated steroid hydroxylase activities in mice. Chem Biol Interact 83: 155-169, 1992.
17. Bjeldanes LF, Kim J-Y, Grose KR, Bartholomew JC and Bradfield CA, Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: Comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci USA 88: 9543-9547, 1991.
18. Bogaards JJP, Verhagen H, Willems Ml, van Poppel G and van Bladeren PJ, Consumption of Brussels sprouts results in elevated α-class glutathione S-transferase levels in human blood plasma. Carcinogenesis 15: 1073-1075, 1994.
19. Shertzer HG, Indole-3-carbinol protects against covalent binding of benzo[a]pyrene and N-nitrosodimethylamine metabolites to mouse liver macromolecules. Chem Biol Interact 48: 81-90, 1984.
20. 1 activation. Biochem Pharmacol 39: 19-26, 1990.
21. Grose KR and Bjeldanes LF, Oligomerization of indole-3-carbinol in aqueous acid. Chem Res Toxicol 5: 188-193, 1992.
22. De Kruif CA, Marsman JW, Venekamp JC, Falke HE, Noordhoek J, Blaauboer BJ and Wortelboer HM, Structure elucidation of acid reaction products of indole-3-carbinol: Detection in vivo and enzyme induction in vitro. Chem Biol Interact 80: 303-315, 1991.
23. Gillner M, Bergman J, Cambillau C, Alexandersson M, Fernström B and Gustafsson JA, Interactions of indolo[3,2-b]carbazoles and related polycyclic aromatic hydrocarbons with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol Pharmacol 44: 336-345, 1993.
24. Poland A and Knutson JC, 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons. Examinations of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22: 517-554, 1982.
25. Goldstein JA and Safe S, Mechanism of action and structure-activity relationships for the chlorinated dibenzo-p-dioxins and related compounds. In: Halogenated Biphenyls, Naphthalenes, Dibenzodioxins and Related Compounds (Eds. Kimbrough RD and Jensen AA), pp. 239-293. Elsevier-North Holland, Amsterdam, 1989.
26. Okey AB, Riddick DS and Harper PA, The Ah receptor: Mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol Lett 70: 1-22, 1994.
27. Whitlock JP Jr, Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu Rev Pharmacol Toxicol 30: 251-277, 1990.
28. Gierthy JF, Lincoln DW, Gillespie MB, Seeger JI, Martinez HL, Dickerman HW and Kumar SA, Suppression of estrogen-regulated extracellular plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res 47: 6198-6203, 1987.
29. Gierthy JF, Bennett JA, Bradley LM and Cutler DS, Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res 53: 3149-3153, 1993.
30. Gierthy JF and Lincoln DW, Inhibition of postconfluent focus production in cultures of MCF-7 breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Breast Cancer Res Treat 12: 227-233, 1988.
31. Biegel L and Safe S, Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160-kDa proteins in human breast cancer cells. J Steroid Biochem Mol Biol 37: 725-732, 1990.
32. Krishnan V and Safe S, Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: Quantitative structure-activity relationships. Toxicol Appl Pharmacol 120: 55-61, 1993.
33. Harper N, Wang X, Liu H and Safe S, Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Mol Cell Endocrinol 104: 47-55, 1994.
34. Zacharewski TR, Bondy KL, McDonell P and Wu ZF, Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression. Cancer Res 54: 2707-2713, 1994.
35. Holcomb M and Safe S, Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Lett 82: 43-47, 1994.
36. Kociba RJ, Keyes DG, Beger JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson LE, Park CL, Barnard SD, Hummel RA and Humiston CG, Results of a 2-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicol Appl Pharmacol 46: 279-303, 1978.
37. Bertazzi PA, Pesatori AC, Consonni D, Tironi A, Landi MT and Zocchetti C, Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Epidemiology 4: 398-406, 1993.
38. Liu H, Wormke M, Safe S and Bjeldanes LF, Indolo[3,2-b]carbazole: A dietary factor which exhibits both antiestrogenic and estrogenic activity. J Natl Cancer Inst 86: 1758-1765, 1994.
39. Tiwari RK, Guo L, Bradlow HL, Telang NT and Osborne MP, Selective responsiveness of breast cancer cells to indole-3-carbinol, a chemopreventative agent. J Natl Cancer Inst 86: 126-131, 1994.
40. Bradlow HL, Telang NT, Osborne MP and Michnovicz JJ, Selective induction of cytochrome P450 enzymes in the prevention of breast cancer. In: The New Biology of Steroid Hormones (Eds. Hochberg RB and Naftolin F), pp. 127-143. Raven Press, New York, 1992.
41. Merchant M, Morrison V, Santostefano M and Safe S, Mechanism of action of aryl hydrocarbon receptor antagonists: Inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression. Arch Biochem Biophys 298: 389-394, 1992.
42. Merchant M, Krishnan V and Safe S, Mechanism of action of α-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells. Toxicol Appl Pharmacol 120: 179-185, 1993.
43. Gasiewicz TA and Rucci G, α-Naphthoflavone acts as an antagonist of 2,3,7,8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor. Mol Pharmacol 40: 607-612, 1991.
44. Harris M, Zacharewski T, Astroff B and Safe S, Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: Mechanistic studies. Mol Pharmacol 35: 729-735, 1989.
45. Astroff B, Zacharewski T, Safe S, Arlotto MP, Parkinson A, Thomas P and Levin W, 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: Inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities. Mol Pharmacol 33: 231-236, 1988.
46. Bannister R, Biegel L, Davis D, Astroff B and Safe S, 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6 mice. Toxicology 54: 139-150, 1989.
47. Pohl RJ and Fouts JR, A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal Biochem 107: 150-155, 1980.
48. Hines RN, Mathis JM and Jacob CS, Identification of multiple regulatory elements on the human cytochrome P4501A1 gene. Carcinogenesis 9: 1599-1605, 1988.
49. Astroff B and Safe S, Comparative antiestrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8-trichlorodibenzofuran in the female rat. Toxicol Appl Pharmacol 95: 435-443, 1988.
50. Zacharewski T, Harris M, Biegel L, Morrison V, Merchant M and Safe S, 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as an antiestrogen in human and rodent cancer cell lines: Evidence for the role of the Ah receptor. Toxicol Appl Pharmacol 13: 311-318, 1992.
51. Safe S, MCDF, 6-methyl-1,3,8-trichlorodibenzofuran. Drugs Future 17: 564-565, 1992.
52. Niwa T, Swaneck G and Bradlow HL, Alterations in estradiol metabolism in MCF-7 cells induced by treatment with indole-3-carbinol and related compounds. Steroids 59: 523-527, 1994.
53. Harris M, Piskorska-Pliszczynska J, Zacharewski T, Romkes M and Safe S, Structure-dependent induction of aryl hydrocarbon hydroxylase in human breast cancer cell lines and characterization of the Ah receptor. Cancer Res 49: 4531-4535, 1989.
54. DeVito MJ, Birnbaum LS, Farland WH and Gasiewicz TA, Comparisons of estimated human body burdens of dioxinlike chemicals and TCDD body burdens in experimentally exposed animals. Environ Health Perspect 103: 820-831, 1995.